News

As part of this alliance, a team of scientists from Translational Genomics Research Institute (TGen) and Applied Biosystems will employ the SOLiD 3 system, Applied Biosystems’s next-generation genomic

Under the terms of the agreement, Spectral will seek FDA approval for Toraymyxin and intends to commercialize the product together with its endotoxin activity assay (EAA), the only

The company has also appointed Renaat Hooff to assume the position of president and CEO. Mr Hooff was previously the company’s executive vice president of operations. William Crouse,

Del’s new headquarters, a 22,000 square foot facility in the Turnberry Lakes Technology Park will feature a digital showroom that will be used as a walk-through showcase of

Small Bone Innovations has received an approvable letter from the FDA for the Scandinavian Total Ankle Replacement system. The approvable letter states that the FDA has concluded its

Emergent BioSolutions, a developer and marketer of immunobiotics, has reported net income of $1.5m, or $0.05 diluted earnings per share for the fourth quarter of 2008, compared to

Biolase Technology, a dental laser company, has renewed and expanded its multi-year licensing and distribution agreement with Henry Schein, a provider of healthcare products and services to office-based

For the year ended December 31, 2008, Acadia reported a net loss of $64.2 million, or $1.73 per share, compared to a net loss of $56.4 million, or

Endo Pharmaceuticals, a specialty pharmaceutical company, has licensed the exclusive rights to develop and market the investigational drug axomadol in the US and Canada from the German pharmaceutical